Artesian-Arts

Phase II trial results demonstrated improvement in cognition with BI 425809 in adult patients with schizophrenia

RIDGEFIELD, Conn., Sept. 14, 2020 /PRNewswire/ —¬†Boehringer Ingelheim today announced the results from a 12-week, placebo-controlled…